ORM1 (orosomucoid 1)

2007-02-01  

Identity

HGNC
LOCATION
9q32
LOCUSID
ALIAS
AGP-A,AGP1,HEL-S-153w,ORM
FUSION GENES

Other Information

Locus ID:

NCBI: 5004
MIM: 138600
HGNC: 8498
Ensembl: ENSG00000229314

Variants:

dbSNP: 5004
ClinVar: 5004
TCGA: ENSG00000229314
COSMIC: ORM1

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000229314ENST00000259396P02763

Expression (GTEx)

0
1000
2000
3000
4000
5000
6000
7000
8000
9000

Pathways

PathwaySourceExternal ID
Immune SystemREACTOMER-HSA-168256
Innate Immune SystemREACTOMER-HSA-168249
HemostasisREACTOMER-HSA-109582
Platelet activation, signaling and aggregationREACTOMER-HSA-76002
Response to elevated platelet cytosolic Ca2+REACTOMER-HSA-76005
Platelet degranulationREACTOMER-HSA-114608
Neutrophil degranulationREACTOMER-HSA-6798695

Protein levels (Protein atlas)

Not detected
Low
Medium
High

PharmGKB

Entity IDNameTypeEvidenceAssociationPKPDPMIDs
PA451906warfarinChemicalVariantAnnotationnot associated19794411

References

Pubmed IDYearTitleCitations
366969132023Multiallelic Copy Number Variation in ORM1 is Associated with Plasma Cell-Free DNA Levels as an Intermediate Phenotype for Venous Thromboembolism.0
376407412023Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization.3
366969132023Multiallelic Copy Number Variation in ORM1 is Associated with Plasma Cell-Free DNA Levels as an Intermediate Phenotype for Venous Thromboembolism.0
376407412023Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization.3
351888652022Characterization of alpha-1-acid glycoprotein as a potential biomarker for breast cancer.5
352723642022Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk.4
357659572022ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma.4
364621342022Evaluation of IFIT3 and ORM1 as Biomarkers for Discriminating Active Tuberculosis from Latent Infection.3
351888652022Characterization of alpha-1-acid glycoprotein as a potential biomarker for breast cancer.5
352723642022Integrated GWAS and Gene Expression Suggest ORM1 as a Potential Regulator of Plasma Levels of Cell-Free DNA and Thrombosis Risk.4
357659572022ORM 1 as a biomarker of increased vascular invasion and decreased sorafenib sensitivity in hepatocellular carcinoma.4
364621342022Evaluation of IFIT3 and ORM1 as Biomarkers for Discriminating Active Tuberculosis from Latent Infection.3
330703812021Different glycoforms of alpha-1-acid glycoprotein contribute to its functional alterations in platelets and neutrophils.4
334599492021miR-362-3p Targets Orosomucoid 1 to Promote Cell Proliferation, Restrain Cell Apoptosis and Thereby Mitigate Hypoxia/Reoxygenation-Induced Cardiomyocytes Injury.3
335802652021Proteomic Profile of Urinary Extracellular Vesicles Identifies AGP1 as a Potential Biomarker of Primary Aldosteronism.9

Citation

Dessen P

ORM1 (orosomucoid 1)

Atlas Genet Cytogenet Oncol Haematol. 2007-02-01

Online version: http://atlasgeneticsoncology.org/gene/45955/case-report-explorer/css/welcome